Supports sample filtration of 1 - 100 L! The depth filter media allows for the removal of various sizes of cells, debris, and tissue fragments.
The "Supracap 50&100 Depth Filter Capsule" efficiently removes various sizes of cells, tissue fragments, and more, using three types of high-performance Seitz depth filter media. The "Seitz Bio 20 Media" is made of high-purity unmodified and modified cellulose membranes, free of inorganic materials. The "Seitz P Series Media" consists of cellulose fibers, filtration aids, and resins. Additionally, the "Seitz HP Series Media" is suitable for filtering solutions containing a high number of dead cells or solids, as well as solutions with particles of various sizes. 【Features of Seitz Bio 20 Media】 ■ High-purity unmodified and modified cellulose membranes, free of inorganic materials ■ Suitable for processing samples with ion sensitivity, such as protein solutions and dialysis fluids ■ Effective in protecting analytical applications such as columns through filtration *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 <Seitz P Series Media> ■ Composed of cellulose fibers, filtration aids (diatomaceous earth and perlite), and resin ■ Removes negatively charged biomolecules (proteins, endotoxins, etc.) and various sizes of cells and cell fragments from cell culture media and blood samples <Seitz HP Series Media> ■ Composed of two different Seitz P series depth filter sheets stacked in layers of high and low permeability (PDD1, PDE2, PDH4, PDK5) ■ Suitable for filtration of solutions containing a high number of dead cells or solids, as well as solutions containing particles of various sizes *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
- Production of recombinant proteins - Recovery and clarification of cultured cell supernatant - Clarification of fermentation broth - Pre-filtration before purification of plasma proteins, serum, and antibodies
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
